2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$515.00-$0.44 (-0.08%)
Price as of Sep 11, 2026 7:56 PM EDT- $130.6BMarket Cap
- 30.65%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$515.00-$0.44 (-0.08%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $515.44 | ||
Change | +$0.88 (+0.17%) | ||
Open | $522.10 | ||
High | $522.10 | ||
Low | $511.81 | ||
Previous Close | $514.56 | ||
Volume | 898,508 | ||
30-Day Average Volume | 1,018,229 | ||
1-Week Change | -5.62% | ||
1-Month Change | -2.68% | ||
1-Year Change | 30.65% | ||
3-Year Change | 48.45% | ||
5-Year Change | 173.34% | ||
Fundamentals | |||
Shares Outstanding | 253.5M | ||
Total Assets | $27.4B | ||
Market Cap | $130.6B | ||
Enterprise Value | $124.5B | ||
Period: QTR TTM FY | |||
Revenue | $3.3B | ||
Net Income | $1.1B | ||
Free Cash Flow | $1.0B | ||
EBIT | $1.4B | ||
EBITDA | $1.4B | ||
Net Working Capital | $8.6B | ||
EPS | $4.31 | ||
Enterprise Value/EBITDA | 86 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 6 | ||
P/E | 120 | ||
PEG | 17 | ||
Price/Free Cash Flow | 129 | ||
Price/Operating Cash Flow | 116 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue